Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response
Vincenzo Giambra(Casa Sollievo della Sofferenza), Alessandra Mangia(Casa Sollievo della Sofferenza), Chiara Cavorsi(Casa Sollievo della Sofferenza), Giovanna Cocomazzi(Casa Sollievo della Sofferenza), Beatrice Totti(Casa Sollievo della Sofferenza), Elisabetta De Santis(Casa Sollievo della Sofferenza), Francesco Giuliani(University of Campania "Luigi Vanvitelli"), Nicola Serra(Unknown), Maria Maddalena Squillante(Casa Sollievo della Sofferenza), Annarita Valeria Piazzolla(Casa Sollievo della Sofferenza)
Cited by 20
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Neo-adjuvant and adjuvant chemotherapy of gastric cancer
|Annals of Oncology|2007|63
The Impact of the Female Genital Microbiota on the Outcome of Assisted Reproduction Treatments
|Microorganisms|2023|46
Hepatitis C virus micro-elimination: Where do we stand?
|World Journal of Gastroenterology|2021|26
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
|International Journal of Molecular Sciences|2024|23